An economic evaluation of home management of malaria in uganda: An interactive markov model

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Lubel, Yoel ^b   Mills, Anne J ^b   Whitty, Christopher J M ^b   Staedke, Sarah G ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; CHLOROQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; FANSIDAR; ANTIMALARIAL AGENT;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DISABILITY; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; ECONOMIC EVALUATION; FEVER; HEALTH CARE FACILITY; HEALTH SERVICE; HIDDEN MARKOV MODEL; HOME CARE; HUMAN; MALARIA; PROBABILITY; UGANDA; COST BENEFIT ANALYSIS; DRUG COMBINATION; ECONOMICS; MANPOWER; NURSING; PRESCHOOL CHILD; THEORETICAL MODEL;

ANTIMALARIALS; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DRUG COMBINATIONS; HOME CARE SERVICES; HUMANS; MALARIA; MARKOV CHAINS; MODELS, THEORETICAL; UGANDA;

EID: 77957892885     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012439     Document Type: Article

References (62)

1. Kager PA (2002) Malaria control: constraints and opportunities. Trop Med Int Health 7: 1042-1046.
2. Moerman F, Lengeler C, Chimumbwa J, Talisuna A, Erhart A, et al. (2003) The contribution of health-care services to a sound and sustainable malaria-control policy. Lancet Infect Dis 3: 99-102.
3. World Health Organization (2004) Scaling up home-based management of malaria: from research to implementation.
4. Ajayi IO, Browne EN, Garshong B, Bateganya F, Yusuf B, et al. (2008) Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites. Malar J 7: 6.
5. D'Alessandro U, Talisuna A, Boelaert M (2005) Editorial: Should artemisinin-based combination treatment be used in the home-based management of malaria? Trop Med Int Health 10: 1-2.
6. Brent AJ, Ahmed I, Ndiritu M, Lewa P, Ngetsa C, et al. (2006) Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study. Lancet 367: 482-488.
7. Maiteki-Sebuguzi C, Jagannathan P, Yau VM, Clark TD, Njama-Meya D, et al. (2008) Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. Malar J 7: 106.
8. Hodel EM, Kabanywanyi AM, Malila A, Zanolari B, Mercier T, et al. (2009) Residual antimalarials in malaria patients from Tanzania-implications on drug efficacy assessment and spread of parasite resistance. PLoS One 4: e8184.
9. Wiseman V, Kim M, Mutabingwa TK, Whitty CJ (2006) Cost-effectiveness study of three antimalarial drug combinations in Tanzania. PLoS Med 3: e373.
10. Snow RW, Eckert E, Teklehaimanot A (2003) Estimating the needs for artesunate-based combination therapy for malaria case-management in Africa. Trends Parasitol 19: 363-369.
11. Hopkins H, Talisuna A, Whitty CJ, Staedke SG (2007) Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidence. Malar J 6: 134.
12. Pagnoni F, Kengeya-Kayondo J, Ridley R, Were W, Nafo-Traore F, et al. (2005) Artemisinin-based combination treatment in home-based management of malaria. Trop Med Int Health 10: 621-622.
13. Chinbuah AM, Gyapong JO, Pagnoni F, Wellington EK, Gyapong M (2006) Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana. Trop Med Int Health 11: 1003-1016.
14. Kolaczinski JH, Ojok N, Opwonya J, Meek S, Collins A (2006) Adherence of community caretakers of children to pre-packaged antimalarial medicines (HOMAPAK) among internally displaced people in Gulu district, Uganda. Malar J 5: 40.
15. Fapohunda B, Plowman B, Azairwe R, Bisorbowa G, Langi P (2004) Home based management of fever strategy in Uganda: survey report.
16. Malimbo M, Mugisha E, Kato F, Karamagi C, Talisuna AO (2006) Caregivers' perceived treatment failure in home-based management of fever among Ugandan children aged less than five years. Malar J 5: 124.
17. Nsabagasani X, Jesca Nsungwa S, Kallander K, Peterson S, Pariyo G, et al. (2007) Home-based management of fever in rural Uganda: community perceptions and provider opinions. Malar J 6: 11.
18. Nsungwa-Sabiiti J, Peterson S, Pariyo G, Ogwal-Okeng J, Petzold MG, et al. (2007) Home-based management of fever and malaria treatment practices in Uganda. Trans R Soc Trop Med Hyg 101: 1199-1207.
19. Tren R, Hess K, Bate R (2009) Drug procurement, the Global Fund and misguided competition policies. Malar J 8: 305.
20. Malik EM, Hanafi K, Ali SH, Ahmed ES, Mohamed KA (2006) Treatment-seeking behaviour for malaria in children under five years of age: implication for home management in rural areas with high seasonal transmission in Sudan. Malar J 5: 60.
21. Mutabingwa TK (2005) Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy! Acta Trop 95: 305-315.
22. Staedke SG, Mwebaza N, Kamya MR, Clark TD, Dorsey G, et al. (2009) Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial. Lancet 373: 1623-1631.
23. Briggs A, Sculpher M (1998) An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 13: 397-409.
24. Roca-Feltrer A, Carneiro I, Armstrong Schellenberg JRM (2008) Estimates of the burden of malaria morbidity in Africa in children under the age of 5 years. Trop Med Int Health 13
25. Breman JG, Egan A, Keusch GT (2001) The intolerable burden of malaria: a new look at the numbers. Am J Trop Med Hyg 64: iv-vii.
26. Marsh K, Snow RW (1999) Malaria transmission and morbidity. Parassitologia 41: 241-246.
27. Lubell Y, Staedke S, Greenwood BM, Kamya MR, Newton P, et al. ((Under review)) Likely health outcomes for untreated acute febrile illnesses in the tropics suggestive of malaria in decision and economic models; a Delphi survey.
28. Bukirwa H, Yeka A, Kamya MR, Talisuna A, Banek K, et al. (2006) Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin Trials 1: e7.
29. Checchi F, Piola P, Kosack C, Ardizzoni E, Klarkowski D, et al. (2004) Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda. Trop Med Int Health 9: 445-450.
30. Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, et al. (2007) Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA 297: 2210-2219.
31. Kamya MR, Yeka A, Bukirwa H, Lugemwa M, Rwakimari JB, et al. (2007) Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. PLoS Clin Trials 2: e20.
32. Priotto G, Kabakyenga J, Pinoges L, Ruiz A, Eriksson T, et al. (2003) Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial. Trans R Soc Trop Med Hyg 97: 325-330.
33. Staedke SG, Mpimbaza A, Kamya MR, Nzarubara BK, Dorsey G, et al. (2004) Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial. Lancet 364: 1950-1957.
34. Yeka A, Banek K, Bakyaita N, Staedke SG, Kamya MR, et al. (2005) Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. PLoS Med 2: e190.
35. Lubell Y, Reyburn H, Mbakilwa H, Mwangi R, Chonya S, et al. (2007) The cost-effectiveness of parasitological diagnosis for malaria-suspected patients in an era of combination therapy. Am J Trop Med Hyg 77: 128-132.
36. Lubell Y, Reyburn H, Mbakilwa H, Mwangi R, Chonya S, et al. (2008) The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. Bmj 336: 202-205.
37. Drummond MF, O'Brien B, Stoddart GL, Torrance GW, Sculpher MJ (2005) Methods for the Economic Evaluation of Health Care Programmes:. Oxford University Press.
38. Conteh L, Sharp BL, Streat E, Barreto A, Konar S (2004) The cost and cost-effectiveness of malaria vector control by residual insecticide house-spraying in southern Mozambique: a rural and urban analysis. Trop Med Int Health 9: 125-132.
39. Rafael ME, Taylor T, Magill A, Lim YW, Girosi F, et al. (2006) Reducing the burden of childhood malaria in Africa: the role of improved diagnostics. Nature 444: Suppl 139-48.
40. WHO Statistical Information System (2007) World Health Statistics 2007, Uganda Life Expectancy Tables. WHO.
41. Edejer TTT, Baltussen R, Adam T, Hutubessy R, Acharya A, et al. (2003) Making Choices in Health: WHO Guide to Cost-effectiveness Analysis. Geneva: World Health Organization.
42. Mathers CD, Bernard C, Moesgaard Iburg K, Inoue M, Ma Fat D, et al. (2002) Global Burden of Disease in 2002: data sources, methods and results.
43. Sachs J (2002) Macroeconomics and health: Investing in health for economic development. Geneva: World Health Organization.
44. United Nations Statistics Division World Statistics Pocketbook - http://data.un.org/CountryProfile.aspx?crName=Uganda.
45. Dorsey G, Njama D, Kamya MR, Cattamanchi A, Kyabayinze D, et al. (2002) Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Lancet 360: 2031-2038.
46. Jensen TP, Bukirwa H, Njama-Meya D, Francis D, Kamya MR, et al. (2009) Use of the slide positivity rate to estimate changes in malaria incidence in a cohort of Ugandan children. Malar J 8: 213.
47. Kleinschmidt I, Sharp B (2001) Patterns in age-specific malaria incidence in a population exposed to low levels of malaria transmission intensity. Trop Med Int Health 6: 986-991.
48. Schellenberg DM, Aponte JJ, Kahigwa EA, Mshinda H, Tanner M, et al. (2003) The incidence of clinical malaria detected by active case detection in children in Ifakara, southern Tanzania. Trans R Soc Trop Med Hyg 97: 647-654.
49. Trape JF, Zoulani A, Quinet MC (1987) Assessment of the incidence and prevalence of clinical malaria in semi-immune children exposed to intense and perennial transmission. Am J Epidemiol 126: 193-201.
50. World Bank (2007) GNI per capita 2005, Atlas method and PPP. World Bank.
51. Kallander K, Nsungwa-Sabiiti J, Peterson S (2004) Symptom overlap for malaria and pneumonia-policy implications for home management strategies. Acta Trop 90: 211-214.
52. Kallander K, Tomson G, Nsungwa-Sabiiti J, Senyonjo Y, Pariyo G, et al. (2006) Community referral in home management of malaria in western Uganda: a case series study. BMC Int Health Hum Rights 6: 2.
53. Kelly JM, Osamba B, Garg RM, Hamel MJ, Lewis JJ, et al. (2001) Community health worker performance in the management of multiple childhood illnesses: Siaya District, Kenya, 1997-2001. Am J Public Health 91: 1617-1624.
54. Winch PJ, Gilroy KE, Wolfheim C, Starbuck ES, Young MW, et al. (2005) Intervention models for the management of children with signs of pneumonia or malaria by community health workers. Health Policy Plan 20: 199-212.
55. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, et al. (2005) Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med 2: e330.
56. Bhattarai A, Ali AS, Kachur SP, Martensson A, Abbas AK, et al. (2007) Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med 4: e309.
57. Guerra CA, Gikandi PW, Tatem AJ, Noor AM, Smith DL, et al. (2008) The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med 5: e38.
58. Nyarango PM, Gebremeskel T, Mebrahtu G, Mufunda J, Abdulmumini U, et al. (2006) A steep decline of malaria morbidity and mortality trends in Eritrea between 2000 and 2004: the effect of combination of control methods. Malar J 5: 33.
59. Okiro EA, Hay SI, Gikandi PW, Sharif SK, Noor AM, et al. (2007) The decline in paediatric malaria admissions on the coast of Kenya. Malar J 6: 151.
60. World Health Organization (2010) Guidelines for the treatment of malaria -2nd edition. Geneva: WHO.
61. Ansah EK, Narh-Bana S, Epokor M, Akanpigbiam S, Quartey AA, et al. (2010) Rapid testing for malaria in settings where microscopy is available and peripheral clinics where only presumptive treatment is available: a randomised controlled trial in Ghana. BMJ 340: c930.
62. Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C (1999) Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med 5: 340-343.